Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88268164 |
LAW OFFICE ASSIGNED |
LAW OFFICE 115 |
MARK SECTION |
MARK |
ELAHERE (see, http://uspto.report/TM/88268164/mark.png) |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
LITERAL ELEMENT |
ELAHERE |
OWNER SECTION (current) |
NAME |
ImmunoGen, Inc. |
MAILING ADDRESS |
830 Winter Street |
CITY |
Waltham |
STATE |
Massachusetts |
ZIP/POSTAL CODE |
02451 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
OWNER SECTION (proposed) |
NAME |
ImmunoGen, Inc. |
MAILING ADDRESS |
830 Winter Street |
CITY |
Waltham |
STATE |
Massachusetts |
ZIP/POSTAL CODE |
02451 |
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY |
United States |
EMAIL |
XXXX |
CORRESPONDENCE INFORMATION (current) |
NAME |
Jenevieve Maerker |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ustrademark@foleyhoag.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
CORRESPONDENCE INFORMATION (proposed) |
NAME |
Jenevieve Maerker |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE |
ustrademark@foleyhoag.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) |
NOT PROVIDED |
DOCKET/REFERENCE NUMBER |
32827.50165 |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
CURRENT IDENTIFICATION |
Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely,
pharmaceutical preparations for treatment of oncological diseases, disorders, and conditions |
GOODS OR SERVICES |
KEEP ALL LISTED |
EXTENSION SECTION |
EXTENSION NUMBER |
3 |
ONGOING EFFORT |
product or service research or development ; steps to obtain required governmental approval |
ALLOWANCE MAIL DATE |
07/09/2019 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
1 |
SUBTOTAL AMOUNT [EXTENSION FEE] |
125 |
TOTAL AMOUNT |
125 |
SIGNATURE SECTION |
SIGNATURE |
/Joseph J Kenny/ |
SIGNATORY'S NAME |
Kenny, Joseph J., Ph.D., J.D. |
SIGNATORY'S POSITION |
Vice President, Acting General Counsel, Intellectual Property and Chief Patent Counsel |
DATE SIGNED |
12/14/2020 |
SIGNATORY'S PHONE NUMBER |
7818950699 |
FILING INFORMATION |
SUBMIT DATE |
Mon Dec 14 13:02:52 ET 2020 |
TEAS STAMP |
USPTO/ESU-XX.XX.XX.XXX-20
201214130252339088-882681
64-750878291f8c5a236807d3
9105628a8a45e50421d352c79
ce6e22e28fc426723027-CC-0
2502838-20201209140830136
783 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005) |
OMB No. 0651-0054 (Exp 12/31/2020) |
SOU Extension Request
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: ELAHERE (see, http://uspto.report/TM/88268164/mark.png)
SERIAL NUMBER: 88268164
OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: ImmunoGen, Inc., having an address of
830 Winter Street
Waltham, Massachusetts 02451
United States
Email: XXXX
Proposed: ImmunoGen, Inc., having an address of
830 Winter Street
Waltham, Massachusetts 02451
United States
Phone:
Fax:
Email: XXXX
The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application. The Notice of Allowance mailing date was 07/09/2019.
For International Class 005:
Current identification: Pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of cancer; pharmaceuticals for human use, namely, pharmaceutical preparations for treatment of
oncological diseases, disorders, and conditions
For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice
of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate
control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this
specific class.
This is the third extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension
request: product or service research or development ; steps to obtain required governmental approval
Correspondence Information (current):
Jenevieve Maerker
PRIMARY EMAIL FOR CORRESPONDENCE: ustrademark@foleyhoag.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Correspondence Information (proposed):
Jenevieve Maerker
PRIMARY EMAIL FOR CORRESPONDENCE: ustrademark@foleyhoag.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all
official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.
Declaration
STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section
1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the
mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of
the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near
resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.
DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and
the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made
on information and belief are believed to be true.
Signature: /Joseph J Kenny/ Date Signed: 12/14/2020
Signatory's Name: Kenny, Joseph J., Ph.D., J.D.
Signatory's Position: Vice President, Acting General Counsel, Intellectual Property and Chief Patent Counsel
Signatory's Phone: 7818950699
RAM Sale Number: 88268164
RAM Accounting Date: 12/14/2020
Serial Number: 88268164
Internet Transmission Date: Mon Dec 14 13:02:52 ET 2020
TEAS Stamp: USPTO/ESU-XX.XX.XX.XXX-20201214130252339
088-88268164-750878291f8c5a236807d391056
28a8a45e50421d352c79ce6e22e28fc426723027
-CC-02502838-20201209140830136783